Led by Mt Sinai Alzheimer’s researcher and thought leader Mary Sano, PhD, and coordinated by the ADCS, the HBA study compared feasibility and efficiency, and ability to capture change over time using in-home instruments, and ability to predict cognitive conversion using pre-defined triggers in a randomized clinical trial.
Watch a Brain Channel round table about educating, training, mentoring and funding young Latino Alzheimer’s scientists.
What’s next in the Raskind/Peskind Prazosin research? They are directing the ADCS’ Peace AD trial which will test Prazosin, as a treatment for disruptive agitation, in people with moderate to severe Alzheimer’s disease. The trial is launching this spring in over 20 memory and long term care communities in the US.
The AlzForum’s editorial team provides a comprehensive recap of the last year in Alzheimer’s research and related public policy developments.
The updated guidelines reflect increased MCI research, the significance of MCI in clinical practice, and therapeutics in trials.